Partnerships
We pursue selected, shared risk /reward partnerships to develop internal IP programmes that address major unmet medical needs.
We combine our internal expertise in venom biology and drug discovery with that of partners who have developed unique phenotypic assays or other biologic tools for identifying drug leads in our venoms' components.
We expect that some of these programmes will generate IP-protected molecules that increase the value of the company. Please contact us to discuss a partnership with Venomtech.
Targeted Venom Arrays
 |
Ion ChannelsNew and exciting approaches to ion-channel pathways |
 |
GPCRsOur peptides are unlocking GPCR targets in many applications |
 |
KinasesOur peptides are providing solutions for research into Kinases |
 |
EpigeneticsEffective solutions for hard-to-hit epigenetic targets |
 |
Antimicrobial ResistanceOur peptides are natural solutions for modulating resistant entities |
 |
S100 ProteinsWe are hitting S100 targets |
